Abdi Ibrahim Pharmaceuticals
Abdi Ibrahim Pharmaceuticals, a leading player in the pharmaceutical industry, is headquartered in Turkey (TR) and operates extensively across various regions. Founded in 1906, the company has established itself as a pioneer in the development and distribution of innovative healthcare solutions. Specialising in a diverse range of therapeutic areas, Abdi Ibrahim offers a unique portfolio of prescription medications, over-the-counter products, and biotechnology solutions. The company is renowned for its commitment to quality and research, which has positioned it as a trusted name in the market. With numerous accolades and a strong market presence, Abdi Ibrahim Pharmaceuticals continues to drive advancements in healthcare, making significant contributions to the well-being of communities both locally and internationally.
DitchCarbon Score
How does Abdi Ibrahim Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abdi Ibrahim Pharmaceuticals's score of 43 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abdi Ibrahim Pharmaceuticals's reported carbon emissions
In 2023, Abdi Ibrahim Pharmaceuticals reported total greenhouse gas emissions of approximately 59,518,000 kg CO2e. This includes 28,607,000 kg CO2e from Scope 1 emissions, 2,179,000 kg CO2e from Scope 2 emissions, and 59,518,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 60% by 2030, using 2020 as the base year. Additionally, Abdi Ibrahim is committed to a 45% reduction in absolute Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C. The company's headquarters is located in Turkey (TR), and it is actively working towards achieving these significant climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 7,067,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 22,720,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 9,621,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abdi Ibrahim Pharmaceuticals is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
